Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
NCT02653833Phase 1Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Change in Skeletal Muscle Blood Flow. Started Nov 2017; status: terminated.
Beyond the preview
Go deeper on NCT02653833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653833.